Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease-Reference-Cited by-同舟云学术

Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease

Published:1988-06 Issue:6 Volume:84 Page:63-69
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Schmidt E.W.,Rasche B.,Ulmer W.T.,Konietzko Nikolaus,Becker Michael,Fallise J.P.,Lorenz J.,Ferlinz R.

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Structure and variation of human alpha-1-antitrypsin;Carrel;Nature,1982

2. Packaging insert of the test “NOR-Partigen” (276) of the Behringwerke AG, Marburg, West Germany (issue of June 1985).

3. Packaging insert of the Beckman alpha-1-antitrypsin (AAT) reagent to be used in conjunction with Beckman's ICS Calibrator II for the quantification of alpha-1-antitrypsin in human serum by rate nephelometry. Beckman Instruments, Inc., Brea, California 92621 (issue of 1983).

4. Evaluation of the protease-antiprotease theory of human destructive lung disease;Gadek;Bull Eur Physiopathol Respir,1980

5. Proteasen-inhibitoren;Fritz,1970

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency;European Respiratory Journal;2017-11

2. Clinical Management and Treatment of Lung Disease;Blanco's Overview of Alpha-1 Antitrypsin Deficiency;2017

3. Development, validation and use of ELISA for antibodies to human alpha-1 antitrypsin;Journal of Immunological Methods;2013-02

4. Intravenous Human Plasma-Derived Augmentation Therapy in α1-Antitrypsin Deficiency: From Pharmacokinetic Analysis to Individualizing Therapy;Annals of Pharmacotherapy;2008-04-15

5. Should Health-Care Systems Pay for Replacement Therapy in Patients With α1-Antitrypsin Deficiency?;Chest;2000-03